USFDA9 Jul 2026, 10:54 am
Piramal Pharma's US FDA Inspection at Sellersville Facility Successfully Closed
AI Summary
Piramal Pharma Ltd has announced the successful closure of the US FDA inspection at its manufacturing facility located in Sellersville, USA. This follows a prior intimation on May 10th, 2026, regarding the inspection. The US FDA has issued an Establishment Inspection Report (EIR), confirming the successful closure of the inspection. This development is positive for the company's regulatory standing and operational compliance in the United States.
Key Highlights
- US FDA inspection at Sellersville facility successfully closed.
- Establishment Inspection Report (EIR) issued by US FDA.
- Confirms regulatory compliance of the US manufacturing site.
- Positive signal for ongoing operations and market access.
Price Impact
More from PPLPHARMA